Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany’s Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission tomography, or PET scans.
In a statement sent to Reuters, Novartis did not confirm the value of the deal but said Siemens Healthineers would remain a partner in the Novartis radioligand therapy business, adding that it expects the transaction to close in the fourth quarter.
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
منبع: YahooFinanceCA - 🏆 47. / 63 ادامه مطلب »
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
منبع: YahooFinanceCA - 🏆 47. / 63 ادامه مطلب »
A German diaspora in North Carolina is booming thanks to a multibillion-dollar investment from Germany, but a potential Trump Presidency is causing anxietyThousands of Germans have flocked to North Carolina in recent years, aided by investments from Siemens and Daimler.
منبع: YahooFinanceCA - 🏆 47. / 63 ادامه مطلب »